Genetic Technologies Ltd.(NASDAQ : GENE)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||2.71%||461.57||2.7%||$556.12m|
|GILD||Gilead Sciences, Inc.||2.20%||64.62||1.0%||$516.91m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.02%||211.98||1.9%||$458.30m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.11%||150.10||2.0%||$339.49m|
|CRSP||CRISPR Therapeutics AG||-0.73%||114.65||0.6%||$304.78m|
|BNGO||BioNano Genomics, Inc.||3.62%||7.15||0.0%||$275.81m|
|EXAS||EXACT Sciences Corp.||0.51%||121.64||18.4%||$251.13m|
|PACB||Pacific Biosciences of California, Inc.||1.70%||29.27||7.2%||$176.23m|
Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.